To be fair to Pfizer, they offered a price almost 30% above the market value at the time and they've also thrown in a "free" $3 million up front R&D payment, which they didn't really need to.
It's that R&D payment that makes the situation interesting and makes it much less likely Pzifer would want to walk away.
- Forums
- ASX - By Stock
- RAP
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-16
-
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online